The University of Queensland

Pre-clinical studies of anti-LAG3 in lymphoma (2017–2019)

Grant type:

Bristol-Myers Squibb Pharmaceuticals Pty Limited

Researchers:

• 

  Professor Maher Gandhi

  Director, MRI & CEO Mater(Conjoint)
  

  Mater Research Institute-UQ

  Faculty of Medicine

Funded by:

Bristol-Myers Squibb Pharmaceuticals Pty Limited